Industry News (Joint Venture)

Agreement Signed To Discover/Develop/Commercialize Antiviral Agents

Published in AIDS Weekly, May 13th, 1996

A joint collaborative research, development and commercialization agreement for the discovery and development of antiviral drugs for hepatitis C and approaches for HIV was announced by Oncogene Science, Inc., Uniondale, New York, and BioChem Therapeutic Inc., Laval, Quebec.

Under the terms of the agreement, both companies commit a team of research scientists to discover treatments for hepatitis C and HIV. The agreement, which calls for shared research, development and commercialization, is for a period of five years, with a review after three years.

"Oncogene Science is at the forefront of drug lead discovery and is a leader in high throughput...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1996-05-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry